Develop, Implement and Maintain Processes that Survive the Product Life Cycle
June 17 - June 19
PHILADELPHIA, United States
FDA has issued many Warning Letters emphasizing data integrity non-compliance primarily in the analytical environment. These serious findings include; having interrupted, missing, deleted and lost data; inadequate records for risk analysis; failure to exercise appropriate controls; failure to validate computer software; failure to establish validation procedures; manipulation and deletion of audit trails; and many more. The time has never been more critical to evaluate and ensure your organization has top-notch compliant procedures. KENX is pleased to announce that our comprehensive Laboratory Data Integrity Compliance Congress is headed to Philadelphia and showcases the protocols, methodology and actions necessary to avoid regulatory action.
This Conference is Co-Located with Analytical Method Development, Validation and Transfer Summit
Personnel in the Following Environments Should Attend:
This event is also appropriate to business development and sales managers that offer innovative solutions for QC laboratory management, validation departments, data collection and statistics.